Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors.
Takayuki ShinoharaDepartment of Fungal Infection, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.ORCID 0000-0001-8804-0645
Masahiro AbeDepartment of Fungal Infection, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.ORCID 0000-0002-6355-716X
Sayoko OikiDepartment of Fungal Infection, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Ami KoizumiDepartment of Fungal Infection, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Amato OtaniDepartment of Fungal Infection, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Harutaka KatanoDepartment of Infectious Disease Pathology, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Yoshitsugu MiyazakiDepartment of Fungal Infection, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.ORCID 0000-0001-8942-0869
Funding
Japan Agency for Medical Research and Development JP24fk0108679 and JP25fk0108679Japan Agency for Medical Research and Development JP24fk0108683Japan Agency for Medical Research and Development JP25fk0108700Japan Agency for Medical Research and Development JP25fk0108732Japan Society for the Promotion of Science 25K19642
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
A zinc-chelating cyclic alkyl polyamine compound is efficient and safe in a murine model of multidrug-resistant · full record | OpenQuestion